Cheng, J; Kozikowski, AP. We need 2C but not 2B: Developing serotonin 2C (5-HT2C) receptor agonists for the treatment of CNS disorders ChemMedChem, 1 Dec 2015, 10 (12), 1963–1967. 1.1 MB. https://doi.org/10.1002/cmdc.201500437 #13
Cheng, J; Giguère, PM; Onajole, OK; Lv, W; Gaisin, A; Gunosewoyo, H; Schmerberg, CM; Pogorelov, VM; Rodriguiz, RM; Vistoli, G; Wetsel, WC; Roth, BL; Kozikowski, AP. Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents J. Med. Chem., 26 Feb 2015, 58 (4), 1992–2002. 1.9 MB. https://doi.org/10.1021/jm5019274 #8 MS,NMR
3-FPBP · 3′-Fluoro-α-(pyrrolidin-1-yl)butanophenone
4F-PBP · 4′-Fluoro-α-(pyrrolidin-1-yl)butanophenone
4′-Fluoro-α-(piperidin-1-yl)propanophenone · FPPPO
3-F-2′-Oxo-PCE · FXE · Fluorexetamine
3-Fluoro-PPPO · 3′-Fluoro-α-(piperidin-1-yl)propanophenone
N-Cyclopentyl-3-fluorocathinone
2-F-2-oxo-Cy-PCE · 2-Fluoro-2-Oxo-PCE